NYSE USD

Quest Diagnostics Incorporated (DGX)

128.44 +2.53 (+2.01%)
At close: April 19 at 4:00 PM EDT
128.40 -0.04 (-0.03%)
After hours: 8:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. James E. Davis Chairman, CEO & President 2.88M -- 1963
Mr. Sam A. Samad Executive VP & CFO 1.33M -- 1970
Mr. Michael E. Prevoznik Senior VP & General Counsel 881.23k -- 1962
Ms. Catherine T. Doherty Executive Vice President of Regional Businesses 1M -- 1963
Mr. Karthik Kuppusamy Ph.D. Senior Vice President of Clinical Solutions 840.3k -- 1970
Mr. Michael J. Deppe Senior VP, Corporate Controller & Chief Accounting Officer -- -- 1967
Ms. Gabrielle Wolfson Senior VP and Chief Information & Digital Officer -- -- --
Mr. Shawn C. Bevec Vice President of Investor Relations -- -- --
Ms. Kristin Lee Wallace Esq. Senior VP & Chief Compliance Officer -- -- --
Mr. Gary D. Samuels Senior VP & Chief Communications Officer -- -- --

Quest Diagnostics Incorporated

500 Plaza Drive
Secaucus, NJ 07094
United States
973 520 2700 https://www.questdiagnostics.com
Sector: 
Healthcare
Full Time Employees: 
40,000

Description

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Corporate Governance

Quest Diagnostics Incorporated’s ISS Governance QualityScore as of April 1, 2024 is 4. The pillar scores are Audit: 4; Board: 9; Shareholder Rights: 1; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Apr 23, 2024
Quest Diagnostics Incorporated Earnings Call

Apr 22, 2024

Dividend Date

Related Tickers

LH Laboratory Corporation of America Holdings
201.48
+1.02%
 
MYGN Myriad Genetics, Inc.
18.50
-0.05%
 
CRL Charles River Laboratories International, Inc.
226.78
-0.34%
 
RVTY Revvity, Inc.
100.86
+1.49%
 
QGEN Qiagen N.V.
40.00
+1.34%
 
IQV IQVIA Holdings Inc.
228.09
+0.40%
 
WAT Waters Corporation
296.10
+0.64%
 
IDXX IDEXX Laboratories, Inc.
476.35
-0.30%
 
ICLR ICON Public Limited Company
288.23
-1.23%
 
MEDP Medpace Holdings, Inc.
372.00
-0.62%